Faculty who have authored publication Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.
| Name | Title | Department | Institution |
|---|---|---|---|
| Mehdi H. Hamadani MD | Professor | Medicine | Medical College of Wisconsin |
| Parameswaran Hari MD | Adjunct Professor | Medicine | Medical College of Wisconsin |
